Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAIR-o study of colchicine versus placebo in women with obesity
NL-OMON54343Completed
- Sponsor
- Radboud University
- Start
- Apr 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of colchicine in obesity and Overweight (2 arms), sponsored by Radboud University. Primary endpoints: Brain activity related to effort and reward valuation and Behavioral weighting of effort and reward valuation. Started Apr 2022; status: completed.
02
Drugs
colchicine
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NL-OMON54343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54343.